Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A Review of the Role of CpG Oligodeoxynucleotides as Toll-Like Receptor 9 Agonists in Prophylactic and Therapeutic Vaccine Development in Infectious Diseases

1 Jan 2008

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Immune Response and Inflammation
Share to Immunotherapy and Immune Responses
Share to Viral gastroenteritis research and epidemiology

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 18457466
DOI: 10.2165/00126839-200809030-00001

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 23 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A Review of the Role of CpG Oligodeoxynucleotides as Toll-Like Receptor 9 Agonists in Prophylactic and Therapeutic Vaccine Development in Infectious DiseasesPMID 18457466Read ↗

Antiinfective Applications of Toll-like Receptor 9 AgonistsSemantic proximity Read ↗

CpG Oligodeoxynucleotides as TLR9 AgonistsSemantic proximity Read ↗

Clinical evaluation of CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases and cancerSemantic proximity Read ↗

CPG Oligonucleotides as Vaccine Adjuvants for Prevention of Infectious DiseasesSemantic proximity Read ↗

TLR9 in health and disease.Semantic proximity Read ↗

A Brief Review on Dna Vaccines in the Era of COVID-19Semantic proximity Read ↗

TLR, NLR Agonists, and Other Immune Modulators as Infectious Disease Vaccine AdjuvantsSemantic proximity Read ↗

Toll-Like Receptor 9 Activation with CpG Oligodeoxynucleotides for Asthma Therapy*Semantic proximity Read ↗

Cutting Edge: CpG Oligodeoxynucleotides Trigger Protective and Curative Th1 Responses in Lethal Murine LeishmaniasisSemantic proximity Read ↗

Protective efficacy of a dengue 2 DNA vaccine in mice and the effect of CpG immuno-stimulatory motifs on antibody responsesSemantic proximity Read ↗

Recognition of CpG oligodeoxynucleotides by human Toll-like receptor 9 and subsequent cytokine induction.Semantic proximity Read ↗

A Guide to Nucleic Acid Vaccines in the Prevention and Treatment of Infectious Diseases and Cancers: From Basic Principles to Current ApplicationsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.